Austin—A new startup that claims it can get consumers cash back on their purchases—and bring its customers more business in the process—has raised $2 million in new seed funding and is preparing to launch out of beta testing. Called Dosh... Read more »
BioClin Therapeutics has raised $30 million in funding to move forward with more tests of its experimental treatment for bladder cancer.
New investors Sofinnova Ventures and Ysios Capital led the Series B round of financing for San Ramon, CA-based BioClin. Earlier... Read more »
Akashi Therapeutics has been cleared by the FDA to resume testing an experimental Duchenne muscular dystrophy drug roughly a year after a patient taking the treatment died in a clinical trial. Now the question is whether the Cambridge, MA, company can... Read more »
Three years ago, Xconomy gathered some of the field’s experts to talk about the promises of harnessing the immune system to fight cancer. Now, it’s time to gather again in Seattle to look back at the last three years and look... Read more »
Year after year, Xconomy has gathered exemplary business leaders, investors, and far-seeing technologists to our most prestigious event—The Napa Summit. This year is no different. Come join us in the heart of wine country on June 8 and 9... Read more »
After a frustrating day at work, we’ve all probably felt the urge to blow off steam by belting out our favorite song or banging on the drums.
Employees at Bullhorn can do that without leaving the office. The business software company’s... Read more »
With ever-smaller smartphones now flaunting the computing powers of yesteryear’s hefty business machines, it might look like Moore’s Law has yet to be repealed. In 1965, Intel co-founder Gordon Moore saw computer chips doubling in processing power every year, and predicted... Read more »
With the healthcare industry navigating the transition from fee-for-service payment models to value-based care, startups and mature healthcare IT companies are building tools to enable this massive business change.
In many cases, the federal agency driving this transition must certify those... Read more »